Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global API Intermediate Market to reach USD 246.77 billion by the end of 2030.

Global API Intermediate Market Size Study & Forecast, by Type (Bulk Drug Intermediates, Chemical Intermediates), by Application (Analgesics, Anti-Infective Drugs, Antidiabetic Drugs, Cardiovascular Drugs, Anticancer Drugs, Others), by End User (Biotech and Pharmaceutical Companies, CMO, Others), and by Regional Analysis, 2023-2030

Product Code: HLSHS-43360439
Publish Date: 30-10-2023
Page: 200

Global API Intermediate Market is valued at approximately USD 139.4 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2023-2030. Active Pharmaceutical Ingredient (API) intermediates commonly referred to as drug intermediates, are chemical compounds or substances formed during the synthesis or manufacturing process of an API. The final active pharmaceutical component utilized in the formulation of medicines is produced from these intermediates, which are the essential building blocks or precursor molecules. API intermediates are used in developing novel pharmaceutical substances. The production of APIs uses compounds known as API intermediates as building blocks or precursors. The quality control processes use API intermediates as reference standards. The surge in demand for generic drugs, the rising trend of contract manufacturing and outsourcing, increase in the prevalence of chronic diseases such as cardiovascular disorders, diabetes, cancer, and respiratory ailments, coupled with the escalating geriatric populations are the key driving factors for the global API Intermediate Market.

In addition, the flourishing growth of the biopharmaceutical industry is acting as a catalyzing factor for the market demand during the estimated period. Biopharmaceuticals are a type of drug that is produced using biological materials, such as proteins, genes, and cells. Biological components including proteins, DNA, and cells are used to make biopharmaceuticals, a specific class of medication. These drugs are extremely popular and are more efficient than conventional small-molecule medicines. The expansion of the biopharmaceutical sector is boosting demand for API intermediates as they are necessary for the creation of biopharmaceuticals. As per Statista, in 2022, it was estimated that the biopharmaceuticals sector account for USD 403.1 billion globally, is expected to continue to grow, and is likely to surpass USD 974.5 billion by 2030. Hence, these factors are bolstering the growth of the API Intermediate Market in the estimated period 2023-2030. Moreover, the growing focus on personalized medicine, as well as increasing investments in research and development present various lucrative opportunities over the forecast years. However, the imposition of stringent government regulations and the limited availability of skilled labor and expertise are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global API Intermediate Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the regional pharmaceutical companies heavily investing in research and development activities to discover new drugs and improve existing drug formulations. Also, advances in pharmaceutical manufacturing techniques, such as continuous manufacturing and the use of process analytical technology (PAT), have improved the efficiency and quality of API production. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. Factors such as the rise in chronic diseases, spurring population, growing demand for affordable healthcare, and the expiration of patents for several branded drugs, along with the expansion of the pharmaceutical industry in emerging economies such as India and China are significantly propelling the market demand across the region.

Major market players included in this report are:
Espee Group
Hikal Ltd
Anyang General Chemical Co., Ltd.
Evonik Industries AG
Sandoo Pharmaceuticals and Chemicals Co., Ltd.
Cambrex Corporation
Sanofi
Cation Pharma
Pfizer Inc.
BASF SE

Recent Developments in the Market:
Ø In March 2022, Sumitomo Chemical Co., Ltd., a Japanese chemical company announced that the company builds a new manufacturing facility for active pharmaceutical ingredients (APIs) and intermediates for small molecule drugs at its Oita Works (Oita City, Oita Prefecture, Japan) to increase its ability to meet the rising demand for small molecule drugs.

Global API Intermediate Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Type, Application, End User, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Bulk Drug Intermediates
Chemical Intermediates

By Application:
Analgesics
Anti-Infective Drugs
Antidiabetic Drugs
Cardiovascular Drugs
Anticancer Drugs
Others

By End User:
Biotech and Pharmaceutical Companies
CMO
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. API Intermediate Market, by Region, 2020-2030 (USD Billion)
1.2.2. API Intermediate Market, by Type, 2020-2030 (USD Billion)
1.2.3. API Intermediate Market, by Application, 2020-2030 (USD Billion)
1.2.4. API Intermediate Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global API Intermediate Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global API Intermediate Market Dynamics
3.1. API Intermediate Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Surge in demand for generic drugs
3.1.1.2. Flourishing growth of the biopharmaceutical industry
3.1.2. Market Challenges
3.1.2.1. Imposition of stringent government regulations
3.1.2.2. Limited availability of skilled labor and expertise
3.1.3. Market Opportunities
3.1.3.1. Growing focus on personalized medicine
3.1.3.2. Increasing investments in research and development
Chapter 4. Global API Intermediate Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global API Intermediate Market, by Type
5.1. Market Snapshot
5.2. Global API Intermediate Market by Type, Performance – Potential Analysis
5.3. Global API Intermediate Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. API Intermediate Market, Sub Segment Analysis
5.4.1. Bulk Drug Intermediates
5.4.2. Chemical Intermediates
Chapter 6. Global API Intermediate Market, by Application
6.1. Market Snapshot
6.2. Global API Intermediate Market by Application, Performance – Potential Analysis
6.3. Global API Intermediate Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. API Intermediate Market, Sub Segment Analysis
6.4.1. Analgesics
6.4.2. Anti-Infective Drugs
6.4.3. Antidiabetic Drugs
6.4.4. Cardiovascular Drugs
6.4.5. Anticancer Drugs
6.4.6. Others
Chapter 7. Global API Intermediate Market, by End User
7.1. Market Snapshot
7.2. Global API Intermediate Market by End User, Performance – Potential Analysis
7.3. Global API Intermediate Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
7.4. API Intermediate Market, Sub Segment Analysis
7.4.1. Biotech and Pharmaceutical Companies
7.4.2. CMO
7.4.3. Others
Chapter 8. Global API Intermediate Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. API Intermediate Market, Regional Market Snapshot
8.4. North America API Intermediate Market
8.4.1. U.S. API Intermediate Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada API Intermediate Market
8.5. Europe API Intermediate Market Snapshot
8.5.1. U.K. API Intermediate Market
8.5.2. Germany API Intermediate Market
8.5.3. France API Intermediate Market
8.5.4. Spain API Intermediate Market
8.5.5. Italy API Intermediate Market
8.5.6. Rest of Europe API Intermediate Market
8.6. Asia-Pacific API Intermediate Market Snapshot
8.6.1. China API Intermediate Market
8.6.2. India API Intermediate Market
8.6.3. Japan API Intermediate Market
8.6.4. Australia API Intermediate Market
8.6.5. South Korea API Intermediate Market
8.6.6. Rest of Asia Pacific API Intermediate Market
8.7. Latin America API Intermediate Market Snapshot
8.7.1. Brazil API Intermediate Market
8.7.2. Mexico API Intermediate Market
8.8. Middle East & Africa API Intermediate Market
8.8.1. Saudi Arabia API Intermediate Market
8.8.2. South Africa API Intermediate Market
8.8.3. Rest of Middle East & Africa API Intermediate Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Espee Group
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Hikal Ltd
9.3.3. Anyang General Chemical Co., Ltd.
9.3.4. Evonik Industries AG
9.3.5. Sandoo Pharmaceuticals and Chemicals Co., Ltd.
9.3.6. Cambrex Corporation
9.3.7. Sanofi
9.3.8. Cation Pharma
9.3.9. Pfizer Inc.
9.3.10. BASF SE
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now